IgAN/FSGS Monitoring Roundtable | Q2 2026
This educational material was developed by independent expert faculty. Sponsors providing unrestricted educational support had no role in faculty selection, content development, conclusions, or dissemination.
Areas of alignment and key monitoring principles from an independent expert roundtable on practical interpretation of longitudinal monitoring in IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS).
Focus: distinguishing meaningful change from expected variability in monitoring inputs, and defining evaluation-only decision points. This material does not provide treatment recommendations.
Content forthcoming
Expected ~7 days post-session
Monitoring Cadence Map + Evaluation Decision Points (~30-day)